Nano-Science Center > Research > Bionano and Nanomedicine > Martinez Group
Martinez Group
The group of Karen L. Martinez explores innovative interfaces of newly developed nano-tools with biological samples for the development of novel biosensors to be used for pharmacological investigation and diagnostics. Such new methods are developed in the perspective of personalized medicine, providing well-suited therapies (better efficiency and limited side effects). Emphasis is put on the exploitation of sensitive membrane proteins because of their crucial roles in numerous pathologies and the potential they represent for future therapies..
Click here for a more detailed description of our projects.
Please use the menu on the right to browse the pages for the Martinez Group >>>
